Patents Assigned to Avertix Medical, Inc.
  • Patent number: 11980450
    Abstract: Systems and Methods are disclosed for detecting acute coronary syndrome (ACS) events, arrythmias, heart rate abnormalities, medication problems such as non-compliance or ineffective amount or type of medication, and demand/supply related cardiac ischemia. The system may have both implanted and external components that communicate with a Physicians's programmer, and smart-devices for monitoring and alerting to detected medically relevant events or states. At least one processor provides event detection using statistical threshold criteria calculated upon at least a portion of a patient's data/distributions and set for a patient or based upon what a doctor determines as abnormal for a patient. Cardiovascular condition is tracked using histogram, trend, and summary information related to heart rate and/or cardiac features such as S-T segment measures of heartbeats.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: May 14, 2024
    Assignee: Avertix Medical, Inc.
    Inventors: David R. Fischell, Michael Sasha John, David Keenan, Steve Johnson, Gregg Turi